Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENDRA Life Sciences Inc. Director's Dealing 2018

Oct 24, 2018

35444_dirs_2018-10-24_3f02c436-6393-4e89-975a-585746693506.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2018-10-22

Reporting Person: Longboard Capital Advisors, LLC (10% Owner)
Reporting Person: Conrad Brett (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-22 Common Stock S 50200 $4.1649 Disposed 379237 Indirect
2018-10-23 Common Stock S 50000 $4.2177 Disposed 329237 Indirect
2018-10-24 Common Stock S 30000 $4.1761 Disposed 299237 Indirect

Footnotes

F1: Longboard Capital Advisors, LLC is the Investment Manager of Grayboard Investments, Ltd. Grayboard Investments Ltd. sold 100,200 shares of Common Stock in Endra Life Sciences, Inc. Grayboard Investments, Ltd. now owns 110,338 shares of Common Stock in Endra Life Sciences, Inc.

F2: Longboard Capital Advisors, LLC is the General Partner of Blue Earth Fund, LP. Blue Earth Fund, LP sold 30,000 shares of Common Stock in Endra Life Sciences, Inc. Blue Earth Fund, LP now owns 188,899 shares of Common Stock in Endra Life Sciences, Inc. The total amount of Common Stock owned by Blue Earth Fund, LP is Grayboard Investments, Ltd. and Blue Earth Fund, LP is 299, 237. There was no change in the amount of Warrants to purchase Common Stock as previously reported.